Mary Qiu

Mary Qiu

Auto-generated profile, based on publicly available information

Mary Qiu

Cole Eye Institute, Cleveland Clinic, 2042 E 102nd St, Cleveland, OH, 44106, USA

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2015 in Ophthalmology
Verified
Journal Article
Closed access
MQMary Qiu
Mary Qiu
Carol ShieldsCarol Shields
Carol Shields

1 August 2017 in Ophthalmology
Verified
Journal Article
Closed access
MQMary Qiu
Mary Qiu
MBMichael V. Boland
Michael V. Boland
PRPradeep Ramulu
Pradeep Ramulu

31 July 2022 in American Journal of Ophthalmology Case Reports
Verified
Journal Article
Open access
JKJacob A. Kanter
Jacob A. Kanter
PAPathik Amin
Pathik Amin
RKRahul Komati
Rahul Komati
AMAnna G. Mackin
Anna G. Mackin
DDDavid Dao
David Dao
MQMary Qiu
Mary Qiu
To report a case of acute neovascular glaucoma with partial synechial angle closure secondary to central retinal vein occlusion that underwent gonioscopy-assisted transluminal trabeculotomy as well as near-monthly anti-vascular endothelial growth factor (VEGF) injections and panretinal photocoagulation (PRP) treatments. Nine months after GATT, the patient had achieved intraocular pressure control on no medications. However, she was lost to follow up for 4 months and received no anti-VEGF or PRP during that time; she re-presented with acute NVG and complete synechial closure, and ultimately underwent aqueous shunt implantation. To our knowledge, this is the first reported attempt of an ab interno angle surgery to successfully restore aqueous outflow through the conventional outflow pathway in an eye with acute NVG and partial synechial angle closure. We posit that this can be an effective approach to achieve IOP control in NVG with at least partially open angles, as long as sufficient anti-neovascular treatments are administered until the underlying neovascular drive achieves quiescence.

6 April 2021 in Journal of Glaucoma
Verified
Journal Article
Closed access
MQMary Qiu
Mary Qiu
FWFasika A. Woreta
Fasika A. Woreta
MBMichael V. Boland
Michael V. Boland
Precis: A cross-sectional sample of the US ophthalmology residency graduating class of 2018 revealed that 18.4% of residents logged <5 traditional glaucoma surgeries, and 63.4% logged at least 1 microinvasive glaucoma surgery (MIGS). Purpose: Describe the state of MIGS in US ophthalmology residency training and propose a glaucoma procedure classification system for residents’ surgical case logs. Methods: Deidentified case logs from residents graduating in 2018 were requested from US residency program directors. Results: Case logs were received for 152/488 (31%) residents from 36/115 (31%) programs. The mean number of traditional glaucoma surgeries per resident was 9.0±5.9 (range: 0 to 31). The mean number of MIGS per resident was 5.2±8.9 cases (range: 0 to 58). There were 28/152 (18.4%) residents from 16/36 (44.4%) programs who logged <5 traditional glaucoma surgeries as primary surgeon, and 3/152 (2.0%) residents from 3/36 (8.3%) programs who logged zero traditional glaucoma surgeries as primary surgeon. There were 98/152 (64.5%) residents from 32/36 (88.8%) programs who logged <5 MIGS as primary surgeon, and 48/152 (31.6%) residents from 25 of 36 (69.4%) programs who logged zero MIGS as primary surgeon. There were 104/152 (63.4%) residents from 33/36 (91.6%) programs who logged at least 1 MIGS as primary surgeon; there were 3/36 (8.3%) residency programs where no resident logged any MIGS as primary surgeon. Conclusions: US ophthalmology residents’ MIGS experience varies widely. Residents can satisfy glaucoma surgery requirements with some MIGS, even in the absence of adequate traditional glaucoma surgeries. We propose a residency case log classification system that better reflects the growing role of MIGS in clinical practice and helps ophthalmic educators more accurately track procedures requiring related skills.

16 July 2023 in Ophthalmology Glaucoma
Verified
Journal Article
Closed access
JZJason Y. Zhang
Jason Y. Zhang
MQMary Qiu
Mary Qiu

1 September 2021 in American Journal of Ophthalmology Case Reports
Verified
Journal Article
Open access
CTChristos N. Theophanous
Christos N. Theophanous
EAEma Avdagic
Ema Avdagic
AFAsim V. Farooq
Asim V. Farooq
DSDimitra Skondra
Dimitra Skondra
MQMary Qiu
Mary Qiu
To describe the presentation and management of a patient with epithelial versus fibrous downgrowth following trabeculectomy surgery and review relevant literature regarding this complication after intraocular surgery. A 52-year-old monocular African-American woman was referred for management of presumed epithelial versus fibrous downgrowth following trabeculectomy surgery. The patient was initially treated with intracameral injections of 5-fluorouracil (x2) and bevacizumab (x1). Cataract extraction, membranectomy, and a third intracameral 5-fluorouracil injection were performed. Intraocular pressure (IOP) elevation was subsequently managed with a superotemporal Ahmed FP7 glaucoma drainage device in the sulcus, followed by an inferonasal Baerveldt 350 glaucoma drainage device in the sulcus. The downgrowth has not progressed and the intraocular pressure remains controlled at the most recent follow-up. This case underscores the risk of this complication following trabeculectomy, the role of a combined medical and surgical approach to management, and the possible need for multiple surgical interventions to control IOP. A review of the literature regarding epithelial and fibrous downgrowth after intraocular surgery was conducted, which highlighted the aggressive nature of these conditions and the range of therapeutic approaches that have been described.